IONIS PHARMACEUTICALS INC (IONS) Stock Earnings & Estimates
NASDAQ:IONS - US4622221004 - Common Stock
60.49 USD
+3 (+5.22%)
60.13 USD
-0.36 (-0.6%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 587.4M -27.53% | 787.647M 34.09% | 705.138M -10.48% | 876.52M 24.30% | 941.31M 7.39% | 1.259B 33.75% | 1.667B 32.41% | 2.258B 35.45% | 2.914B 29.05% | 3.246B 11.39% | 3.727B 14.82% | |
| EBITDA YoY % growth | -393.5M -3,492.24% | -311.232M 20.91% | -453.091M -45.58% | -398.405M 12.07% | -473.539M -18.86% | -189.905M 59.90% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -410.2M -6,411.11% | -333.73M 18.64% | -475.081M -42.35% | -412.34M 13.21% | -500.987M -21.50% | -230.033M 54.08% | 72.825M 131.66% | 566.79M 678.29% | 1.212B 113.84% | 1.281B 5.69% | 1.64B 28.02% | |
| Operating Margin | -69.83% | -42.37% | -67.37% | -47.04% | -53.22% | -18.27% | 4.37% | 25.10% | 41.59% | 39.46% | 44.00% | |
| EPS YoY % growth | -2.89 -660.53% | -2.56 11.42% | -3.04 -18.75% | -2.57 15.47% | -2.94 -14.34% | -1.80 38.85% | 1.22 168.03% | 3.48 184.57% | 5.63 61.73% | 6.30 12.00% | 7.72 22.61% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.25 -31.36% | -1.30 -97.58% | -0.82 11.71% | -0.72 -202.58% | -0.54 56.52% | -0.40 69.49% |
| Revenue Q2Q % growth | 133.07M -0.69% | 144.81M -36.21% | 187.69M 42.19% | 212.33M -53.02% | 234.66M 76.34% | 276.71M 91.08% |
| EBITDA Q2Q % growth | -200.048M -51.63% | -211.171M -137.72% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -201.301M -35.41% | -215.125M -94.12% | -134.615M 8.34% | -119.228M -185.27% | -113.623M 43.56% | -92.55M 56.98% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.70 255.56% | -0.44 | 1.14 | 259.57% |
| Q1 2025 Q2Q % growth | -0.93 5.10% | -1.14 | 0.21 | 18.36% |
| Q4 2024 Q2Q % growth | -0.66 -1,000.00% | -1.15 | 0.49 | 42.39% |
| Q3 2024 Q2Q % growth | -0.95 7.77% | -1.18 | 0.23 | 19.50% |
| Q2 2024 Q2Q % growth | -0.45 25.00% | -0.94 | 0.49 | 52.10% |
| Q1 2024 Q2Q % growth | -0.98 -12.64% | -1.07 | 0.09 | 8.61% |
| Q4 2023 Q2Q % growth | -0.06 95.59% | -0.85 | 0.79 | 92.92% |
| Q3 2023 Q2Q % growth | -1.03 -212.12% | -1.06 | 0.03 | 2.99% |
| Q2 2023 Q2Q % growth | -0.60 18.92% | -0.92 | 0.32 | 34.77% |
| Q1 2023 Q2Q % growth | -0.87 -89.13% | -0.93 | 0.06 | 6.36% |
| Q4 2022 Q2Q % growth | -1.36 -196.45% | -0.94 | -0.42 | -44.37% |
| Q3 2022 Q2Q % growth | -0.33 43.10% | -0.76 | 0.43 | 56.43% |
| Q2 2022 Q2Q % growth | -0.74 -29.82% | -0.64 | -0.10 | -16.37% |
| Q1 2022 Q2Q % growth | -0.46 28.13% | -0.73 | 0.27 | 36.60% |
| Q4 2021 Q2Q % growth | 1.41 220.45% | 0.29 | 1.12 | 391.36% |
| Q3 2021 Q2Q % growth | -0.58 -163.64% | -0.54 | -0.04 | -8.24% |
| Q2 2021 Q2Q % growth | -0.57 -147.83% | -0.61 | 0.04 | 6.57% |
| Q1 2021 Q2Q % growth | -0.64 -82.86% | -0.54 | -0.10 | -19.44% |
| Q4 2020 Q2Q % growth | 0.44 -68.79% | 0.29 | 0.15 | 52.87% |
| Q3 2020 Q2Q % growth | -0.22 -222.22% | -0.10 | -0.12 | -127.88% |
| Q2 2020 Q2Q % growth | -0.23 -2,200.00% | -0.28 | 0.05 | 18.04% |
| Q1 2020 Q2Q % growth | -0.35 -156.45% | -0.13 | -0.22 | -171.77% |
| Q4 2019 Q2Q % growth | 1.41 | 0.95 | 0.46 | 48.46% |
| Q3 2019 Q2Q % growth | 0.18 | -0.33 | 0.51 | 154.66% |
| Q2 2019 Q2Q % growth | -0.01 | -0.28 | 0.27 | 96.38% |
| Q1 2019 Q2Q % growth | 0.62 | 0.60 | 0.02 | 3.43% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 452M 100.67% | 301.08M | 150.92M | 50.13% |
| Q1 2025 Q2Q % growth | 132M 10.92% | 127.83M | 4.17M | 3.26% |
| Q4 2024 Q2Q % growth | 227M -30.15% | 140.36M | 86.64M | 61.73% |
| Q3 2024 Q2Q % growth | 134M -6.94% | 132.73M | 1.27M | 0.96% |
| Q2 2024 Q2Q % growth | 225.25M 19.81% | 153.07M | 72.18M | 47.15% |
| Q1 2024 Q2Q % growth | 119M -9.16% | 138.65M | -19.65M | -14.17% |
| Q4 2023 Q2Q % growth | 325M 113.96% | 178.25M | 146.75M | 82.33% |
| Q3 2023 Q2Q % growth | 144M -9.89% | 135.56M | 8.44M | 6.23% |
| Q2 2023 Q2Q % growth | 188M 40.51% | 141.6M | 46.4M | 32.77% |
| Q1 2023 Q2Q % growth | 131M -7.68% | 130.68M | 320K | 0.24% |
| Q4 2022 Q2Q % growth | 151.9M -65.48% | 161.82M | -9.92M | -6.13% |
| Q3 2022 Q2Q % growth | 159.8M 20.06% | 146.77M | 13.03M | 8.88% |
| Q2 2022 Q2Q % growth | 133.8M 6.36% | 143.33M | -9.53M | -6.65% |
| Q1 2022 Q2Q % growth | 141.9M 27.15% | 127.72M | 14.18M | 11.10% |
| Q4 2021 Q2Q % growth | 440M 51.57% | 264.33M | 175.67M | 66.46% |
| Q3 2021 Q2Q % growth | 133.1M -16.86% | 161.55M | -28.45M | -17.61% |
| Q2 2021 Q2Q % growth | 125.8M -13.54% | 139.04M | -13.24M | -9.52% |
| Q1 2021 Q2Q % growth | 111.6M -16.34% | 131.16M | -19.56M | -14.91% |
| Q4 2020 Q2Q % growth | 290.3M -41.20% | 279.97M | 10.33M | 3.69% |
| Q3 2020 Q2Q % growth | 160.1M -4.65% | 185.78M | -25.68M | -13.82% |
| Q2 2020 Q2Q % growth | 145.5M -11.17% | 151.85M | -6.35M | -4.18% |
| Q1 2020 Q2Q % growth | 133.4M -55.11% | 164.35M | -30.95M | -18.83% |
| Q4 2019 Q2Q % growth | 493.7M | 417.47M | 76.23M | 18.26% |
| Q3 2019 Q2Q % growth | 167.9M | 156.87M | 11.03M | 7.03% |
| Q2 2019 Q2Q % growth | 163.8M | 154.04M | 9.76M | 6.34% |
| Q1 2019 Q2Q % growth | 297.2M | 290.94M | 6.26M | 2.15% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -22.6% | -31.56% | 18.32% | 20.64% |
| Revenue | -4.93% | -24.52% | 13.83% | 16.02% |